Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-06
DOI
10.1038/s41467-021-24902-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
- (2020) Jerry B. Harvey et al. Frontiers in Immunology
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
- (2020) Lorenzo Galluzzi et al. Journal for ImmunoTherapy of Cancer
- NIR-Triggered Sequentially Responsive Nanocarriers Amplified Cascade Synergistic Effect of Chemo-Photodynamic Therapy with Inspired Antitumor Immunity
- (2020) Feiyang Jin et al. ACS Applied Materials & Interfaces
- Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors
- (2020) Kuo-Ching Mei et al. ACS Nano
- Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases
- (2020) Zongmin Zhao et al. Nature Biomedical Engineering
- Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy
- (2019) Ting Zhao et al. CARBOHYDRATE POLYMERS
- Immunogenic cell death in cancer therapy: Present and emerging inducers
- (2019) Jingyi Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- pH and Thermal Dual-Sensitive Nanoparticle-Mediated Synergistic Antitumor Effect of Immunotherapy and Microwave Thermotherapy
- (2019) Jing Qi et al. NANO LETTERS
- Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes
- (2019) Di Liu et al. BIOMATERIALS
- Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- Targeting adenosine for cancer immunotherapy
- (2018) Robert D. Leone et al. Journal for ImmunoTherapy of Cancer
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Cell-mediated delivery of synthetic nano- and microparticles
- (2017) Maxime Ayer et al. JOURNAL OF CONTROLLED RELEASE
- Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
- (2017) Jingwei Xue et al. Nature Nanotechnology
- T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
- (2017) Daniela Schmid et al. Nature Communications
- Super natural killer cells that target metastases in the tumor draining lymph nodes
- (2016) Siddarth Chandrasekaran et al. BIOMATERIALS
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer
- (2016) Stephen M Hatfield et al. CURRENT OPINION IN PHARMACOLOGY
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
- (2015) Bonnie Huang et al. Science Translational Medicine
- Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
- (2015) Paul A. Beavis et al. Cancer Immunology Research
- Design Strategies and Applications of Circulating Cell-Mediated Drug Delivery Systems
- (2015) Yixue Su et al. ACS Biomaterials-Science & Engineering
- Design Strategies and Applications of Circulating Cell-Mediated Drug Delivery Systems
- (2015) Yixue Su et al. ACS Biomaterials Science & Engineering
- Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
- (2014) Zhenghong Xu et al. ACS Nano
- Leukocytes as carriers for targeted cancer drug delivery
- (2014) Michael J Mitchell et al. Expert Opinion on Drug Delivery
- Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles
- (2014) Aaron C. Anselmo et al. JOURNAL OF CONTROLLED RELEASE
- TRAIL-coated leukocytes that kill cancer cells in the circulation
- (2014) M. J. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors
- (2013) Paul A. Beavis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
- (2010) Matthias T Stephan et al. NATURE MEDICINE
- Adenosine receptors in regulation of dendritic cell differentiation and function
- (2008) S. V. Novitskiy et al. BLOOD
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now